Met Life Investment Management, LLC Vera Therapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 22,778 shares of VERA stock, worth $852,808. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,778
Previous 22,778
-0.0%
Holding current value
$852,808
Previous $824,000
22.09%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding VERA
# of Institutions
183Shares Held
55.6MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$161 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$147 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$125 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$111 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$105 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.01B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...